Overview

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether treatment with quetiapine XR (Seroquel XR) tablets for 3 weeks will improve their agitation when they have acute psychosis.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Quetiapine Fumarate